Search
for
Sort by
Research 481–510 of 1000+
- Research Advances in Therapeutic Strategies and Drug Delivery Systems for Pathological Scars
- Exploring the Role of GLP‐1 Agents in Managing Diabetic Foot Ulcers: A Narrative and Systematic Review
- Application of mesenchymal stem cells for anti-senescence and clinical challenges
- Syndecan-1 Is Required to Maintain Intradermal Fat and Prevent Cold Stress
- Resveratrol-Loaded Versatile Nanovesicle for Alopecia Therapy via Comprehensive Strategies
- Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in polycystic ovary syndrome (PCOS) women compared to drug-naive PCOS women
- Effects of Glucagon-like Peptide-1 Receptor Agonists on Skin Homeostasis and Skin Aging Processes
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- Research progress and strategies for the biosynthesis of keratinocyte growth factor-2 (KGF-2) in <i>Arabidopsis thaliana</i>
- Targeted Self-Assembled anti-NFκB AuNCs-Aptamer Nanoplatform for Precise Theranostics via Tailored Follicle Regeneration
- Netherton syndrome subtypes share IL-17/IL-36 signature with distinct IFN-α and allergic responses
- The Role of PGC-1α in Aging Skin Barrier Function
- Associations between type 1 diabetes and autoimmune skin diseases: Mendelian randomization analysis
- Identification of sirtuin 1 as a promising therapeutic target for hypertrophic scars
- Type 1 Diabetes Mellitus and Autoimmune Diseases: A Critical Review of the Association and the Application of Personalized Medicine
- Production of a 135-residue long N-truncated human keratinocyte growth factor 1 in Escherichia coli
- Drug interactions between common dermatological medications and the oral anti-COVID-19 agents nirmatrelvir-ritonavir and molnupiravir
- Image 1_Resident T cell activation leads to human hair follicle immune privilege loss ex vivo, which is prevented by the DHODH inhibitor farudodstat: relevance for alopecia areata.pdf
- Natural Product-Inspired Bis(trifluoromethyl) Phenyl Hydroxycinnamate Derivatives as Promising Nonsteroidal Inhibitors of Human Steroid 5α-Reductase Type-1: Synthesis, <i>In Vitro</i>, and <i>In Silico</i> Studies
- Iron Chelators in the Management of Autoimmune-Induced Alopecia: A Focus on Hypoxia-Inducible Factor 1 Modulation and Hair Restoration
- Clinical and biological impact of the exposome on the skin
- Alternative treatment of polycystic ovary syndrome: pre-clinical and clinical basis for using plant-based drugs
- Traction Alopecia
- Efficacy, safety, and Pharmacoeconomics of Three Common Strategies for Pediatric Alopecia Areata Patients: A Retrospective Cohort Study
- Electrospun Nanofibers for Improved Angiogenesis: Promises for Tissue Engineering Applications
- Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
- Testosterone target therapy: focus on immune response, controversies and clinical implications in patients with COVID-19 infection
- Dermal Fibrosis and the Current Scope of Hydrogel Strategies for Scarless Wound Healing
- Malate-based polyester chemically shielded metal-phenolic networks coated artificial hair fibers with long-lasting antimicrobial and anti-inflammatory performance
- Plant-based approaches in the management of polycystic ovary syndrome: A review